PALI — Palisade Bio Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: BUY

Price: $1.16 Analyst target: $9.80 Upside: 744.83%

About Palisade Bio Inc

Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company is headquartered in Carlsbad, California.

See the full interactive analysis & chart →

Informational only — not investment advice.